No Data
'Embarassing And Frankly Shameful': Popular Crypto Influencer Slams Kamala Harris's Crypto Regulatory Plan
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26
Donald Trump Extends Betting Odds Lead To 58:42—Here's How Kamala Harris Plans To Reverse The Trend
Immuneering Rises on Orphan Drug Designation for Treatment of Pancreatic Cancer
Trump Vs. Harris: Vice President Goes From Deficit To Slender Lead In New Poll But Battleground States Favor Ex-President, 14% Undecided Voters Up For Grabs
From Sacking Gary Gensler To Spending Crypto Without Incurring Separate Taxation, Top Analyst Has A Wishlist For Kamala Harris On Digital Assets